"Checkpoint inhibitors"@en . "Chemotherapy"@en . . "Gene expression profiling"@en . . "Precision medicine"@en . "Efficacy"@en . "Time Factors"@en . "Allogenic haematopoietic stem cell transplantation"@en . . "Ibrutinib"@fr . "Adenine"@fr . "Idelalisib"@fr . "Safety"@en . "Reproducibility of Results"@fr . "LC-MS/MS"@fr . "Immunotherapy"@en . "Tandem Mass Spectrometry"@fr . "Lymphoma"@fr . "Male"@en . "Progression"@en . "Anti-PD1"@en . "High Pressure Liquid"@fr . "Cerebrospinal fluid"@fr . "Risk stratification"@en . "Hodgkin lymphoma"@en . "B-Cell"@fr . . "Chromatography"@fr . "Aspergillosis"@en . . "Hodgkin''s lymphoma"@fr . "Charles Herbaux" . <0000-0003-4910-476X> . "Herbaux" . "Nivolumab"@en . "Polyradiculopathy"@fr . "Indolent"@en . "Waldenstr\u00F6m macroglobulinemia"@en . "Humans"@fr . "Hodgkin's Lymphoma"@en . "Peripheral T cell lymphoma"@en . "B-cell malignancies"@fr . "Dihydrodiol-ibrutinib"@fr . "BACH2"@en . "Lymphocytic"@en . "Pyrazoles"@fr . "Multiple myeloma"@en . "Charles" . . "Pyrimidines"@fr . "Cell Therapy and Immunotherapy"@en . . "Re-sensitization"@en . "Chronic"@en . "Limit of Detection"@fr . "Physiopathology"@en . "Female"@en . "Anti-PD-1"@en . "Leukemia"@en . "Bendamustine"@en . .